Oxagen Limited, a biopharmaceutical company, provides drug discovery and development solutions. It offers molecule drugs for the treatment of asthma, autoimmune disease, inflammatory bowel, psoriasis, allergy, and rheumatoid arthritis diseases....

Founded in 1997
Total money raised: $26.7M

OX14 4RY 91 Milton Park


Phone: +44 (0) 1235 443300

Updated on Nov 25, 2009
Oxagen at CrunchBase
Graham Boulnois Chairman and a Director
Mark Payton CEO
John Bell Co-Founder
Stuart J. M. Collinson Director
Dr. Anja König Board Positions
Bryan M. Dechairo Principal Scientist
Roy Pettipher

November, 2009

Oxagen raised $26.7M in a Series C round from Novartis Venture Fund, MPM Capital, SV Life Sciences, Advent Venture Partners, Bessemer Venture Partners, Omega Funds, Abingworth, Red Abbey Venture Partners, and Wellcome Trust

Oxagen rounds up $26.7M in VC


Oxagen was founded in 1997